Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > OPEN AT .10 EH

<< Previous

Bullboard Posts

Next >>

Comment by Dollarpeeon Mar 15, 2020 9:24am

117 Views

Post# 30809307

RE:RE:RE:RE:OPEN AT .10 EH

wannjackson12 wrote: Just hype around uncertainty or do they have something that might get this SP to RUN??

Well, this is what i think. For a company that hit $6 Sp in 2011, has a product that works and working on it to treat COVID19 patients plus the pandemic state of the virus. The stock won't only fly but soar higher. I hope this helps...

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023